REX Peptides ETF (PEPT)
27.01
+0.12
(+0.43%)
USD |
NASDAQ |
Oct 30, 16:00
27.59
+0.58
(+2.16%)
After-Hours: 20:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.65% | 0.13% | 1.888M | -- |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| -- | -- | -- |
Basic Info
| Investment Strategy | |
| The Fund seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an index comprised of companies in the peptides industry. The Fund seeks to track the investment results, before fees and expenses, of the VettaFi Peptide Index (the Index). |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | REX Shares |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of October 31, 2026.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Basic Info
| Investment Strategy | |
| The Fund seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an index comprised of companies in the peptides industry. The Fund seeks to track the investment results, before fees and expenses, of the VettaFi Peptide Index (the Index). |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | REX Shares |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |